The top two proteins, namely neurocan (NCAN) and brevican (BCAN) core proteins, identified from analyses of PTSD–MCI versus controls showed monotonically decreasing protein expression patterns across the PTSD-only and MCI-only subgroups, suggesting that these proteins are candidate biomarkers for disease burden characterized by co-occurrence of PTSD and MCI. This evidence concerns the gene BCAN and post-traumatic stress disorder.